A Phase I/II Pharmacodynamic Study of Hydroxychloroquine in Combination With FOLFOX Plus Bevacizumab to Inhibit Autophagy in Colorectal Cancer
Latest Information Update: 18 Sep 2021
At a glance
- Drugs Bevacizumab (Primary) ; Fluorouracil (Primary) ; Folinic acid (Primary) ; Hydroxychloroquine (Primary) ; Oxaliplatin (Primary)
- Indications Adenocarcinoma; Colon cancer; Rectal cancer
- Focus Biomarker; Pharmacodynamics; Therapeutic Use
- 18 Apr 2019 Biomarkers information updated
- 02 Mar 2013 New trial record